KOREA PHARMA Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 47.55 million compared to KRW 425.1 million a year ago. Net income was KRW 73.18 million compared to KRW 546.18 million a year ago.

Basic earnings per share from continuing operations was KRW 7 compared to KRW 50 a year ago. Basic earnings per share was KRW 7 compared to KRW 50 a year ago.